← Back to Search

Diagnostic Test

Enhanced Monitoring for Atrial Fibrillation (CATCH-AF Trial)

N/A
Waitlist Available
Led By Markus Sikkel, MD
Research Sponsored by Victoria Cardiac Arrhythmia Trials
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

CATCH-AF Trial Summary

This trial is investigating whether the Kardia Mobile monitoring device is a superior strategy for diagnosing Atrial Fibrillation (AF) in comparison to normal ambulatory monitoring with a 24-hour Holter monitor.

Who is the study for?
This trial is for adults over 18 who have symptoms like palpitations or shortness of breath, which could be due to an irregular heartbeat. They must not have been diagnosed with atrial fibrillation before but should have at least one stroke risk factor according to the CHADS2 score.Check my eligibility
What is being tested?
The study compares two ways of diagnosing Atrial Fibrillation: using a Kardia Mobile device continuously when symptoms occur versus a standard 24-hour Holter monitor. Participants are randomly assigned to one of these monitoring methods.See study design
What are the potential side effects?
There are generally no side effects associated with using either the Kardia Mobile or Holter monitoring devices as they are non-invasive tools used to record heart activity.

CATCH-AF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18.

CATCH-AF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to atrial fibrillation diagnosis compared between arms as analysed by Kaplan-Meier survival curves

CATCH-AF Trial Design

2Treatment groups
Active Control
Group I: Enhanced MonitoringActive Control2 Interventions
Kardia/AliveCor monitoring with additional Holter monitoring as needed
Group II: Standard of CareActive Control1 Intervention
Holter monitoring

Find a Location

Who is running the clinical trial?

Victoria Cardiac Arrhythmia TrialsLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
Markus Sikkel, MDPrincipal InvestigatorVictoria Cardiac Arrhythmia Trials Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are engaging in this medical experiment?

"Affirmative. Data hosted on clinicaltrials.gov indicates that this research, which was first made available to the public on December 18th 2018, is currently recruiting participants. All told, 220 individuals are needed to be sourced from 1 medical centre."

Answered by AI

Are there any openings available for participants in this trial?

"Indeed, details available on clinicaltrials.gov show that this trial is still accepting participants, having been initially posted in December 2018 and updated most recently at the end of August 2022. A total of 220 enrollees are required for the single medical center involved in this study."

Answered by AI
~12 spots leftby Apr 2025